Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Brummer

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
ESMO Gastrointestinal Oncology|February 6, 2026
Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignanciesL Weiss, D Zhang, W G Kunz, et al.
Blood Cancer Journal|August 23, 2014
Depletion of STAT5 blocks TEL-SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in miceC Sprissler, D Belenki, H Maurer, et al.
Oncogene|July 4, 2012
Functional characterization of cancer-associated Gab1 mutationsC Ortiz-Padilla, D Gallego-Ortega, B C Browne, et al.
Leukemia|August 4, 2012
Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitorsF U Wöhrle, S Halbach, K Aumann, et al.
Leukemia|May 10, 2017
MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantationN Stickel, K Hanke, D Marschner, et al.
Leukemia|November 20, 2015
Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signalingM Kordes, M Röring, C Heining, et al.
ESMO Open|July 15, 2025
Treatment outcome of NSCLC patients with BRAF<sup>non-V600E</sup> mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in GermanyC Kropf-Sanchen, A Rasokat, P Christopoulos, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
ESMO Gastrointestinal Oncology|February 6, 2026
Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignanciesL Weiss, D Zhang, W G Kunz, et al.
Blood Cancer Journal|August 23, 2014
Depletion of STAT5 blocks TEL-SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in miceC Sprissler, D Belenki, H Maurer, et al.
Oncogene|July 4, 2012
Functional characterization of cancer-associated Gab1 mutationsC Ortiz-Padilla, D Gallego-Ortega, B C Browne, et al.
Leukemia|August 4, 2012
Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitorsF U Wöhrle, S Halbach, K Aumann, et al.
Leukemia|May 10, 2017
MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantationN Stickel, K Hanke, D Marschner, et al.
Leukemia|November 20, 2015
Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signalingM Kordes, M Röring, C Heining, et al.
ESMO Open|July 15, 2025
Treatment outcome of NSCLC patients with BRAF<sup>non-V600E</sup> mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in GermanyC Kropf-Sanchen, A Rasokat, P Christopoulos, et al.
Pageof 2